Antibodies As Promising Novel Neuroprotective Agents in the Central Nervous System Injuries
Journal:
Central Nervous System Agents in Medicinal Chemistry
Volume:
8
Page:
143-169
Author(s):
Hari Shanker Sharma and Aruna Sharma
Clinical Trials of Targeted Alpha Therapy for Cancer
Journal:
Reviews on Recent Clinical Trials
Volume:
3
Page:
185-191
Author(s):
Barry J. Allen
Chromatin Remodeling Agents for Cancer Therapy
Journal:
Reviews on Recent Clinical Trials
Volume:
3
Page:
192-203
Author(s):
La Sala Dario, Magnano Anna Rosa, Estenoz Mariela, Giordano Roberto and Cinti Caterina
Targeted Therapies – Many Ways to (the Peace of) Rome
Journal:
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume:
8
Page:
200-206
Author(s):
Martin Aringer and Josef S. Smolen
Novel Epigenetic Targets in Lymphoproliferative Disorders
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
378-391
Author(s):
Julio Delgado
Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
392-403
Author(s):
Ethan Amir, Sarah Hughes, Fiona Blackhall, Nick Thatcher, Gyula Ostoros, Jozsef Timar, Jozsef Tovari, Gabor Kovacs and Balazs Dome
Modulation of Cellular Response to Anticancer Treatment by Caffeine: Inhibition of Cell Cycle Checkpoints, DNA Repair and More
Journal:
Current Pharmaceutical Biotechnology
Volume:
9
Page:
325-336
Author(s):
Michal Sabisz and Andrzej Skladanowski
Role of mTOR in Hematological Malignancies
Journal:
Current Cancer Therapy Reviews
Volume:
4
Page:
211-218
Author(s):
Uzma Athar and Ajeet Gajra
Polymorphisms of Human N-Acetyltransferases and Cancer Risk
Journal:
Current Drug Metabolism
Volume:
9
Page:
520-531
Author(s):
Jose A.G Agundez
Therapeutic Drug Monitoring of Busulfan in Transplantation
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
1936-1949
Author(s):
J. A. Russell and S. B. Kangarloo